Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Mar 14, 2023 | Option Exercise | $5.47 | 35,879 | 196,258 | 304,345 | Mar 16, 2023, 05:08 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Mar 15, 2022 | Sale | $7.63 | 11,469 | 87,551 | 100,546 | Mar 17, 2022, 05:58 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | May 24, 2021 | Option Exercise | $18.22 | 14,897 | 271,423 | 110,994 | May 26, 2021, 08:00 AM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Mar 15, 2021 | Sale | $38.23 | 8,053 | 307,889 | 71,231 | Mar 17, 2021, 05:00 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Jan 14, 2021 | Sale | $30.77 | 15,000 | 461,610 | 1,172,744 | Jan 19, 2021, 04:31 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Jan 15, 2021 | Sale | $32.26 | 15,000 | 483,859 | 1,164,048 | Jan 19, 2021, 04:31 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Nov 16, 2020 | Sale | $32.88 | 15,000 | 493,146 | 1,192,961 | Nov 18, 2020, 04:36 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Oct 15, 2020 | Sale | $40.49 | 15,000 | 607,392 | 1,207,491 | Oct 16, 2020, 06:55 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Sep 21, 2020 | Sale | $35.30 | 15,000 | 529,545 | 1,217,706 | Sep 22, 2020, 04:48 PM | |
RLMD | RELMADA THERAPEUTICS, INC. | SCHMIDT ERIC THOMAS | Director | Apr 09, 2020 | Option Exercise | $6.83 | 45,000 | 307,500 | 100,000 | Apr 09, 2020, 04:37 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Mar 16, 2020 | Sale | $19.73 | 5,450 | 107,508 | 47,906 | Mar 18, 2020, 04:32 PM | |
ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | Chief Financial Officer | Feb 20, 2020 | Option Exercise | $25.30 | 237,155 | 6,000,021 | 1,227,595 | Feb 24, 2020, 05:14 PM |